Gus Attridge — Aspen Pharmacare — South African tycoon — Johannesburg Stock Exchange — South Africa — Hot News
Aspen’s market slump wipes $52 million from South African tycoon Gus Attridge’s stake
Attridge, who serves as the group’s chief advisor, holds a 4.3-percent stake in the Durban-based pharmaceutical giant, amounting to 19,033,829 shares.
Related
South African businessman Gus Attridge sees Aspen stake drop by $9.3 million
This corresponds to a 5.24 percent drop in Aspen’s stock price on the Johannesburg Stock Exchange (JSE) in 9 days.
Gus Attridge's Aspen stake down $39 million so far in 2024
This corresponds to an 18.12 percent drop in Aspen’s stock price on the Johannesburg Stock Exchange (JSE) since the start of the year.
Gus Attridge’s stake in Africa’s largest pharma company drops by $16.5 million
South African pharma mogul Gus Attridge loses $16.5 million from stake in Africa’s largest pharmaceutical company.
Latest
Glencore, led by South Africa's Gary Nagle, explores merger talks with Rio Tinto
Glencore and Rio Tinto are in advanced talks for a merger that could reshape the global mining sector, rivaling industry leader BHP Group.
Nigeria’s richest banker Jim Ovia gains $8 million from Zenith Bank shares
This follows a tough 2024 marked by Nigeria's currency devaluation and economic challenges that weakened Ovia's investments.
Kenafric, led by Kenya’s Shah family, set for $100 million stake sale by private equity firms
The private equity firms have enlisted Nedbank Group to lead the sale process.
Moroccan real estate mogul Alami Lazraq sees $53 million wealth boost
Over the past sixteen days, his shares have increased by MAD536.49 million ($53.62 million), continuing the upward momentum seen throughout 2024.